PIONEERING A NEW APPROACH
TO THE OPIOID CRISIS

Learn More

Atelerix is a preclinical biotech company developing a platform technology of novel small molecules targeting unmet medical needs arising from the opioid crisis.

IN THE HOSPITAL:
Post surgery respiratory depression

IN THE COMMUNITY:
WITHDRAWAL/TOLERANCE/ADDICTION/GI MOBILITY

IN THE FIELD:
FIRST RESPONDERS/COMBAT/ MASS CAUSALITIES